MOOLEC SCIENCE SA(MLEC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MLEC MOOLEC SCIENCE SA

Pre-Mkt 12-31 04:06:36 EST

0.2657

+0.0124

+4.90%

盘前0.2193

-0.0464-17.46%

04:05 EST

High0.2798	Low0.2399	Vol4.65M
Open0.2400	D1 Closing0.2533	Amplitude15.75%
Mkt Cap2.89M	Tradable Cap239.29K	Total Shares10.89M
T/O1.47M	T/O Rate516.68%	Tradable Shares900.60K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MLEC","market":"US","secType":"STK","nameCN":"MOOLEC SCIENCE SA","latestPrice":0.2657,"timestamp":1767128400000,"preClose":0.2533,"halted":0,"volume":4653197,"hourTrading":{"tag":"盘前","latestPrice":0.2193,"preClose":0.2657,"latestTime":"04:05 EST","volume":130,"amount":28.769,"timestamp":1767171939180},"delay":0,"floatShares":900600,"shares":10891800,"eps":-2.1,"marketStatus":"Pre-Mkt","change":0.0124,"latestTime":"12-31 04:06:36 EST","open":0.24,"high":0.2798,"low":0.2399,"amount":1466433.76943971,"amplitude":0.157521,"askPrice":0.243,"askSize":200,"bidPrice":0.0967,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.1,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1767191400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.2657,"preHourTrading":{"tag":"盘前","latestPrice":0.2193,"preClose":0.2657,"latestTime":"04:05 EST","volume":130,"amount":28.769,"timestamp":1767171939180},"postHourTrading":{"tag":"盘后","latestPrice":0.2389,"preClose":0.2657,"latestTime":"19:59 EST","volume":3824487,"amount":1172731.131283,"timestamp":1767142799109},"volumeRatio":9.452234},"requestUrl":"/m/hq/s/MLEC","defaultTab":"news","newsList":[{"id":"2592582779","title":"Moolec Science Approves Share Consolidation at Extraordinary Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592582779","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592582779?lang=en_us&edition=fundamental","pubTime":"2025-12-17 06:28","pubTimestamp":1765924139,"startTime":"0","endTime":"0","summary":"Moolec Science SA has approved a share consolidation at a ratio ranging from 1-for-10 to 1-for-25, with the exact ratio to be determined by the Board at a later date. The consolidation will affect both issued and unissued ordinary shares, and any fractional shares resulting from the process will be rounded up to the nearest whole share. The change is set to take effect on a date between December 17, 2025 and May 14, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moolec Science SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 16, 2025, and is solely responsible for the inf","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDLbD9XMM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","MLEC"],"gpt_icon":0},{"id":"2587737550","title":"BRIEF-Moolec Science Received Non-Compliance Letter From Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2587737550","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587737550?lang=en_us&edition=fundamental","pubTime":"2025-11-29 04:40","pubTimestamp":1764362436,"startTime":"0","endTime":"0","summary":"BRIEF-Moolec Science Received Non-Compliance Letter From Nasdaq Nov 28 (Reuters) - Moolec Science SA MLEC.O:MOOLEC SCIENCE: RECEIVED LETTER FROM NASDAQ THAT CO NOT IN COMPLIANCE WITH NASDAQ LISTING RULE 5250(C)(1)Source text: [ID:n0001213900-25-116005]Further company coverage: MLEC.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nFWN3X40DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLEC","BK4212"],"gpt_icon":0},{"id":"2587732801","title":"Moolec Science: Received Letter From Nasdaq That Co Not in Compliance With Nasdaq Listing Rule 5250(C)(1)","url":"https://stock-news.laohu8.com/highlight/detail?id=2587732801","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587732801?lang=en_us&edition=fundamental","pubTime":"2025-11-29 03:25","pubTimestamp":1764357908,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nFWN3X40DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLEC","BK4212"],"gpt_icon":0},{"id":"2587734967","title":"Moolec Science receives Nasdaq determination letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2587734967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587734967?lang=en_us&edition=fundamental","pubTime":"2025-11-29 02:20","pubTimestamp":1764354008,"startTime":"0","endTime":"0","summary":"On November 24, Moolec Science (MLEC) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market stating that the comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moolec-science-receives-nasdaq-determination-letter-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moolec-science-receives-nasdaq-determination-letter-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QLD","TSYW.SI",".IXIC","QID","SQQQ","MLEC","USJW.SI","NVIW.SI","TQQQ","PSQ","NQmain","USAW.SI","BK4212","MNQmain"],"gpt_icon":0},{"id":"2587731003","title":"Moolec Science Misses Deadline for Annual Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2587731003","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587731003?lang=en_us&edition=fundamental","pubTime":"2025-11-29 02:15","pubTimestamp":1764353716,"startTime":"0","endTime":"0","summary":"Moolec Science SA has disclosed a delay in filing its Annual Report on Form 20-F for the financial year ended June 30, 2025. The company cited complexities arising from a recent business combination as the reason for the delay and is working to complete the filing before a Nasdaq panel hearing scheduled for December 18, 2025. Moolec's shares will continue to trade on Nasdaq during this period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moolec Science SA published the original content used to generate this news brief via ACCESS Newswire  on November 28, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL2Sh5Jd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","MLEC"],"gpt_icon":0},{"id":"2580361291","title":"Moolec Science Delays Annual Report Filing Amid Financial Uncertainties","url":"https://stock-news.laohu8.com/highlight/detail?id=2580361291","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580361291?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:04","pubTimestamp":1762167874,"startTime":"0","endTime":"0","summary":"Moolec Science SA has announced a delay in filing its Annual Report on Form 20-F for the fiscal year ended June 30, 2025. The company cited complexities arising from a recent business combination, changes in control, and restructuring efforts, including defaults and debt restructuring by related entities, as reasons for the delay. Management is addressing the resulting uncertainties affecting the company's consolidated financial position.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moolec Science SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 03, 2025, and is solely respon","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL1XvZkR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLEC","BK4212"],"gpt_icon":0},{"id":"2577800912","title":"Moolec Science Sa - Intends to Vigorously Defend Its Position and Enforce Its Rights Under the Agreement With Invim","url":"https://stock-news.laohu8.com/highlight/detail?id=2577800912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577800912?lang=en_us&edition=fundamental","pubTime":"2025-10-22 05:21","pubTimestamp":1761081668,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nFWN3W221D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4212","MLEC"],"gpt_icon":0},{"id":"2577480099","title":"Moolec Science Sa - on October 20, Delivered a Formal Response Letter to Invim, Rejecting Invim’s Assertions and Reserving All Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2577480099","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577480099?lang=en_us&edition=fundamental","pubTime":"2025-10-22 05:21","pubTimestamp":1761081668,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nFWN3W221D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4212","MLEC"],"gpt_icon":0},{"id":"2566987349","title":"Moolec Unit Gets Argentina Regulatory Approval for Technology; CFO Named -- Shares up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2566987349","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566987349?lang=en_us&edition=fundamental","pubTime":"2025-09-11 20:00","pubTimestamp":1757592051,"startTime":"0","endTime":"0","summary":"Moolec Science's  namesake unit said Thursday it received regulatory approval in Argentina for its safflower GLASO technology and appointed Valeria Falottico as chief financial officer.The approval allows the company to expand its safflower crop enriched in gamma-linolenic acid.Moolec said that Chief Executive Alejandro Antalich temporarily assumed the CFO role during the company's restructuring. Falottico has served in senior leadership roles in multinational organizations.In the US, Moolec is advancing its safflower production season with duplicated acreage, compared with last year's crop, it said.The company's shares were up nearly 12% in recent premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MLEC","BK4212"],"gpt_icon":0},{"id":"2566967895","title":"Moolec Science SA Expands U.S. Safflower Acreage and Secures Regulatory Approval in Argentina, Enhancing Global Protein Solutions Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2566967895","media":"Reuters","labels":["executive","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566967895?lang=en_us&edition=fundamental","pubTime":"2025-09-11 19:01","pubTimestamp":1757588466,"startTime":"0","endTime":"0","summary":"Moolec Science SA Expands U.S. Safflower Acreage and Secures Regulatory Approval in Argentina, Enhancing Global Protein Solutions Portfolio. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moolec Science SA published the original content used to generate this news brief via ACCESS Newswire  on September 11, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL1FbFqS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLEC","BK4212"],"gpt_icon":0},{"id":"2558649179","title":"Moolec Science SA Issues Pro Forma Financial Statements Highlighting Strategic M&A with Bioceres Group, Gentle Tech, and Nutrecon","url":"https://stock-news.laohu8.com/highlight/detail?id=2558649179","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558649179?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:05","pubTimestamp":1754996727,"startTime":"0","endTime":"0","summary":"Moolec Science SA Issues Pro Forma Financial Statements Highlighting Strategic M&A with Bioceres Group, Gentle Tech, and Nutrecon. Moolec Science SA has released its unaudited pro forma condensed combined financial statements, providing insights into the financial aspects following its strategic business combination with Bioceres Group, Gentle Tech, and Nutrecon. This merger and acquisition transaction, formalized on June 16, 2025, has resulted in an expanded company structure with Moolec as the parent entity. The financial statements, prepared under the acquisition method of accounting in accordance with IFRS 3, reflect the historical financial data of Moolec and Bioceres Group. The statements are intended to aid stakeholders in analyzing the financial implications of the business combination, although they do not include potential cost savings or synergies expected post-integration. The pro forma adjustments are based on current information and assumptions, with actual future adjustm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL5tRxlK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","MLEC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.moolecscience.com","stockEarnings":[{"period":"1week","weight":0.1472},{"period":"1month","weight":-0.3358},{"period":"3month","weight":-0.7143},{"period":"6month","weight":-0.956},{"period":"1year","weight":-0.9659},{"period":"ytd","weight":-0.9668}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.0053},{"period":"3month","weight":0.0278},{"period":"6month","weight":0.0986},{"period":"1year","weight":0.1679},{"period":"ytd","weight":0.1722}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.20249},{"month":2,"riseRate":0.5,"avgChangeRate":0.005439},{"month":3,"riseRate":0.25,"avgChangeRate":-0.198487},{"month":4,"riseRate":0.8,"avgChangeRate":0.008366},{"month":5,"riseRate":0.6,"avgChangeRate":-0.001977},{"month":6,"riseRate":0.6,"avgChangeRate":-0.009441},{"month":7,"riseRate":0.4,"avgChangeRate":-0.149774},{"month":8,"riseRate":0.4,"avgChangeRate":-0.129421},{"month":9,"riseRate":0.6,"avgChangeRate":-0.076709},{"month":10,"riseRate":0.4,"avgChangeRate":-0.103792},{"month":11,"riseRate":0.6,"avgChangeRate":-0.059607},{"month":12,"riseRate":0.2,"avgChangeRate":-0.048802}],"exchange":"NASDAQ","name":"MOOLEC SCIENCE SA","nameEN":"MOOLEC SCIENCE SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MOOLEC SCIENCE SA(MLEC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MOOLEC SCIENCE SA(MLEC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MOOLEC SCIENCE SA,MLEC,MOOLEC SCIENCE SA股票,MOOLEC SCIENCE SA股票老虎,MOOLEC SCIENCE SA股票老虎国际,MOOLEC SCIENCE SA行情,MOOLEC SCIENCE SA股票行情,MOOLEC SCIENCE SA股价,MOOLEC SCIENCE SA股市,MOOLEC SCIENCE SA股票价格,MOOLEC SCIENCE SA股票交易,MOOLEC SCIENCE SA股票购买,MOOLEC SCIENCE SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MOOLEC SCIENCE SA(MLEC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MOOLEC SCIENCE SA(MLEC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction